U.S., June 24 -- ClinicalTrials.gov registry received information related to the study (NCT07663838) titled 'A Randomized, Multicenter, Open-label, Active-controlled Phase Ib Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Multiple Intravaginal Doses of GenSci142 in Patients With Bacterial Vaginosis (BV)' on June 05.
Brief Summary: A randomized, multicenter, open-label, active-controlled Phase Ib study to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of multiple intravaginal doses of GenSci142 in patients with bacterial vaginosis (BV).
Study Start Date: June 15
Study Type: INTERVENTIONAL
Condition:
Randomized
Open-label
Safety
Tolerability
Pharmacokinetics
Bacter...